Key points are not available for this paper at this time.
The underlying causes of the variation in waiting times observed here are not explained by the audit data, and we do not suggest that there are "across the board" implications for clinical outcome in the waiting times reported.Clearly, these are clinical issues and would vary with specific types of cancer.However, the focus on reducing unnecessary delays in cancer treatment stems from the belief that the earlier disease is detected, the more quickly multidisciplinary care can be instigated and the better the outcome.Irrespective of the specific waiting times reported here, the key contribution of this study is in establishing baseline data which can be used to set targets for improvement and, crucially, to monitor such attempts.We thank Dr Stephen Green for his advice on the development
George Davey Smith (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: